There is no 2026 Surviving Sepsis Campaign guideline published yet—the most current version is from 2021, with the 2016 guidelines being the most extensively detailed in the evidence provided.
The evidence references 1 and 2 mention "2026" guidelines, but these are commentary articles discussing anticipated updates, not the actual published guidelines themselves. The most recent official Surviving Sepsis Campaign guidelines available are from 2021, with the 2016 version 3, 4 providing the comprehensive framework that remains largely applicable.
Key Management Recommendations for Adult Sepsis (Based on 2016/2021 Guidelines)
Initial Resuscitation & Screening
Hospitals must implement routine sepsis screening for acutely ill, high-risk patients to enable earlier treatment initiation 3. This is a performance improvement mandate, not optional.
Antimicrobial Therapy
- Administer IV antimicrobials within 1 hour of recognizing sepsis or septic shock 3
- Start empiric broad-spectrum therapy covering all likely pathogens (bacterial, fungal, viral as appropriate) before culture results 3
- Obtain at least 2 sets of blood cultures (aerobic and anaerobic) before antibiotics, but do not delay antimicrobials beyond 45 minutes 3
- Reassess daily for de-escalation once pathogen identified 3
- Typical duration: 7-10 days (longer for slow responders, undrained foci, S. aureus bacteremia, immunocompromised) 3
- Use procalcitonin to guide discontinuation in culture-negative cases 3
Fluid Resuscitation
Crystalloids are the first-line fluid choice 3, 4:
- Initial bolus: minimum 30 mL/kg crystalloids for sepsis-induced hypoperfusion 3
- Either balanced crystalloids or normal saline acceptable 3
- Add albumin when substantial crystalloid volumes required 3
- Never use hydroxyethyl starches (strong contraindication) 3
- Continue fluid challenges as long as hemodynamic parameters improve 3
Vasopressor Management
Norepinephrine is the first-choice vasopressor, targeting MAP ≥65 mmHg 3, 4:
Escalation algorithm:
- Start norepinephrine
- Add vasopressin (0.03 U/min) OR epinephrine to raise MAP or reduce norepinephrine dose 3
- Do not use low-dose dopamine for renal protection (strong contraindication) 3
- Dopamine only for highly selected patients with bradycardia and low arrhythmia risk 3
- Phenylephrine reserved for: norepinephrine-induced arrhythmias, high cardiac output with persistent hypotension, or salvage therapy 3
- Add dobutamine (up to 20 μg/kg/min) for persistent hypoperfusion despite adequate fluids and vasopressors 3
Place arterial catheter as soon as practical in all patients requiring vasopressors 3
Source Control
Identify and control infection source as rapidly as possible, implementing intervention within 12 hours of diagnosis 3, 4:
- Use least invasive effective method (percutaneous over surgical drainage) 3
- Remove infected intravascular devices promptly after establishing alternative access 3, 4
- Delay intervention for infected pancreatic necrosis until demarcation occurs 3, 4
Corticosteroids
Do not routinely use hydrocortisone if adequate fluid resuscitation and vasopressors restore hemodynamic stability 3. If vasopressors fail to stabilize patient, consider hydrocortisone 200 mg/day IV, tapered when vasopressors discontinued 3.
Blood Product Management
- Transfuse RBCs only when hemoglobin <7.0 g/dL (target 7.0-9.0 g/dL) once tissue hypoperfusion resolved 3
- Do not use antithrombin 3
- Prophylactic platelets: <10,000/mm³ without bleeding; <20,000/mm³ with bleeding risk; ≥50,000/mm³ for active bleeding or procedures 3
Important Caveats
The 2021 guidelines (referenced in 5, 6) provide targeted updates emphasizing individualized treatment, structured post-discharge follow-up, and patient-centered care beyond acute management. German S3 guidelines from 2025 5, 6 adapted these international recommendations with focus on prevention and long-term quality of life.
The anticipated 2026 update 1 is expected to emphasize risk-stratified precision medicine, whole-course management extending beyond acute phase, and recommendations adapted for resource-limited settings—but these are not yet officially published.